Search

Maria Villalba (Ecole Polytechnique Fédérale de Lausanne, Switzerland) and colleagues describe in PNAS their new optical nanomotion method to test single-bacterium viability and antibiotic response in 1-2 hours using a basic microscope, a c

Lene Bens (KU Leuven, Belgium) and colleagues published a perspective on phage therapy for Hidradenitis Suppurativa, highlighting the unique challenge and opportunity for personalized treatment of a complex, inflammatory disease.

Streptomyces lividans, a model filamentous Gram-positive bacterium with conserved contractile-injection-system gene clusters, makes phage tail-like particles (SLPs) that stay in the cytoplasm instead of being released. Without SLPs, aerial

The Evergreen International Phage Meeting is happening Aug 6-11, 2023, live in Olympia, Washington, USA! This is an in-person meeting, better known as Phage Camp! Come present your phage work, climb mountains with other phage scientists, pl

Dear phage researchers, You’re invited to participate in a new initiative to draft guidelines for managing phage banks, led by Tobi Nagel (Phages for Global Health) and Francesca Hodges (Innovate UK KTN). Stage 1 (online survey: OPEN NOW):

Phage Therapy Today released a podcast featuring Dr. Frenk Smrekar, founder and CEO at JAFRAL, discussing the importance of Good Manufacturing Practices (GMP) in phage therapy.

The special edition of "Microorganisms" titled "The Phage: Biology and Therapeutic Use" is open. Guest editors David Harper and Richard James invite you to submit by July 31, 2023.

Adaptive Phage Therapeutics has entered into a collaboration and license agreement with the Israeli Phage Therapy Center of the Hebrew University of Jerusalem and Hadassah Medical Center. The agreement grants APT exclusive rights to make, u

Adaptive Phage Therapeutics has received $12 million from Deerfield Management and the AMR Action Fund as part of a new $24 million investment.

PhageLab is a Chile-based AI-powered phage biotech company selling phage biocontrol to livestock producers. Their technology is a deep epidemiological analysis algorithm that identifies phages to match target bacteria, based on unique data

Primary sclerosing cholangitis (PSC) is a chronic, progressive liver disease. Masataka Ichikawa (Keio University, Japan) and colleagues from BiomX have shown in a new paper that oral and oral+IV administration of a phage cocktail supresses

Thu Vu Phuc Nguyen and colleagues have a new preprint showing that when multiple phages infect the same cell, they slow or even prevent each other from entering the cell. Check out his Twitter thread!

Attention all phage researchers! You’re invited to participate in an exciting initiative to help establish draft phage bank management guidelines for the community. Please register your interest in participating here. The process will unf

This week Phagecast published a new episode featuring an interview with Martin Loessner! You can hear very valuable insights in what is important to have a successful scientific career together with some phage science: how L-forms become re

The Evergreen International Phage Meeting is happening Aug 6-11, 2023, live in Olympia, Washington, USA! This is an in-person meeting, better known as Phage Camp! Come present your phage work, climb mountains with other phage scientists, pl

The Evergreen Phage Meeting organizing committee invite you to take part in a photo contest and get a chance to win awesome phage swag! Send us your favorite photo featuring or taken with Betty Kutter, and let's shower her with love at the

The UK phage biotech company, Fixed Phage, has appointed Dr Neil Clelland as its new CEO, along with a new COO and Executive Chairman. The company is looking to build on its position in the phage industry and provide innovative solutions fo

Sabrina Green and colleagues published a retrospective observational study of 12 cases of expanded access customized phage therapy. They found that customized phage production and therapy was safe and yielded favorable clinical or microbiol

Due to technical limitations, most gut microbiome studies have focused on prokaryotes, overlooking viruses. Yishay Pinto and colleagues have published a new paper on Phanta: a new method for quickly and simply identifying and quantifying ph

Agnès Oromí-Bosch and colleagues published a new report on phage resistance-related challenges associated with phage therapy. They review two main strategies for mitigating resistance in phage therapy: 1) smartly identify/design the phages